In addition, neoantigens needs to be processed and presented by antigen presenting cells (APC) to effectively activate CD8+ T cells, which indicates that the number and function of infiltrating immune cells in tumor microenvironment are more important for the effectiveness of immunotherapy [58]. This evidence concerns the gene CD8A and neoplasm.